Recruiting

Identifying Predictors Of Response To Mepolizumab In CRSwNP

Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Code:

NCT05902325

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mepolizumab 100 MG Injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information